Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia. - Wikidata - wikimedia - TriplyDB

Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia.

Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia.

http://www.wikidata.org/entity/Q40449095

about

Differentiation therapy of leukemia: 3 decades of development.Gut Microbiota Species Can Provoke both Inflammatory and Tolerogenic Immune Responses in Human Dendritic Cells Mediated by Retinoic Acid Receptor Alpha Ligation.Differentiation therapy in poor risk myeloid malignancies: Results of a dose finding study of the combination bryostatin-1 and GM-CSF.Bryostatin-1, Fenretinide and 1α,25 (OH)(2)D(3) Induce Growth Inhibition, Apoptosis and Differentiation in T and B Cell-Derived Acute Lymphoblastic Leukemia Cell Lines (CCRF-CEM and Nalm-6)Induction of acute lymphocytic leukemia differentiation by maintenance therapy Myeloablative allogeneic bone marrow transplant using T cell depleted allografts followed by post-transplant GM-CSF in high-risk myelodysplastic syndromes.Unlocking the potential of retinoic acid in anticancer therapy.Anti-cancer effects of 20(S)-protopanoxadiol on human acute lymphoblastic leukemia cell lines Reh and RS4;11.Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors.Early mitochondrial alterations in ATRA-induced cell death.

P2860

Q33409795-79A8379F-5099-4A44-9600-75D3613667B7 Q33571508-2BA91202-8D06-491A-86B8-BFEEDAF4BFE9 Q34549158-99FC2A1E-D46E-4944-8722-9AFA448B6BD1 Q36571416-4240EC93-0EDB-4E93-A04B-0CAC60773422 Q37098221-A94A3202-33A8-4406-9AD3-8F1BA7F2D329 Q37286248-D7857663-7C54-4AB3-9C68-ABEC5914B469 Q38269931-8408B6E0-CE2A-4B8D-875D-883DE32AD43F Q39720700-772A816B-ACCC-4531-9F28-250766586911 Q40393545-4DE7D43C-057B-4281-98D5-F86051E4F05A Q40400306-C6697E83-2C7C-422E-8160-50F24C1324B4

P2860

Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia.

http://www.wikidata.org/entity/Q40449095

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Requirement for myeloid growth ...... acute promyelocytic leukaemia.

@en

type

label

Requirement for myeloid growth ...... acute promyelocytic leukaemia.

@en

prefLabel

Requirement for myeloid growth ...... acute promyelocytic leukaemia.

@en

P1433

Q40449095-B529A8EE-B428-45CD-BE2F-E380C9B38BA2

P1476

Q40449095-A98360A0-07F2-4361-B987-4A98B5B4AEA6

P2093

Q40449095-3F768C79-163A-4E59-88CD-3AC41D107C22

Q40449095-48616006-C372-46A2-900F-84C616EDB13C

Q40449095-53F3FB43-8CE0-4FF6-A735-2F9D048A8EF9

Q40449095-5DA6A37E-FB0C-4FAF-BE2F-1A9EC2B98B20

Q40449095-8D1DB559-9FEF-4BAA-A8EA-DCF7AC76B56A

Q40449095-C5FCEA59-476F-470F-A7C3-F8C123A7E9D3

P2860

Q40449095-03370576-55AC-43DE-969A-6F6CC3CCA3DE

Q40449095-041727BD-1801-45B4-8907-4A923AAEC799

Q40449095-06A38E85-2125-444E-890E-A67AA3A13B52

Q40449095-09C1C371-F35C-404E-9118-3B0D27B6AC44

Q40449095-12F04931-EA18-4BCB-A70C-BFB7C93C3781

Q40449095-134F1C98-48C1-4231-86C7-C6F0592A0296

Q40449095-1DB485F4-5D9E-4B61-8E32-FC083C2B0B48

Q40449095-2B051B07-50E5-4566-ADA8-3FDC7E2EAF93

Q40449095-44544658-7C2B-4560-90F4-64B3E164EFE3

Q40449095-4DA0AD58-D0AD-4F69-BBB4-6FC62C66DEDE

P304

Q40449095-40804F05-EB4A-4534-96A5-1814C39B4329

P31

Q40449095-6C468649-8ECC-46C5-A5CF-85EEA2FCFB03

P356

Q40449095-4034B4DD-B663-4C41-9203-A6F3F22B26D1

P407

Q40449095-396D906B-BEFD-4DCF-BBFE-581F73FAA277

P433

Q40449095-71318718-E8BB-44C7-A3E8-6E6397D208AD

P478

Q40449095-16C186C1-01B7-44F9-8918-266FCC65FD13

P50

Q40449095-8509D3F6-49ED-40FE-A085-64DC37A836E4

P577

Q40449095-006DEFED-E055-4641-BE1D-469C05F2BB9F

P5875

Q40449095-CB549B1C-C5EE-402D-BAA5-135563BD16FF

P698

Q40449095-4AD8E1F1-30CC-43C8-8B20-4D3E1113E39A

P921

Q40449095-A3C249B1-6FF2-42F8-A5C3-D1E4CB5BC368

P356

J.1365-2141.2005.05395.X

P1433

British Journal of Haematology

P1476

Requirement for myeloid growth ...... acute promyelocytic leukaemia.

@en

P2093

B Douglas Smith

http://www.w3.org/2001/XMLSchema#string

Carol Ann Huff

http://www.w3.org/2001/XMLSchema#string

Louis F Diehl

http://www.w3.org/2001/XMLSchema#string

Milada Vala

http://www.w3.org/2001/XMLSchema#string

Nikeshia Beal

http://www.w3.org/2001/XMLSchema#string

Richard J Jones

http://www.w3.org/2001/XMLSchema#string

P2860

Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML

The role of PML in tumor suppression

All-trans-retinoic acid in acute promyelocytic leukemia

The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR

Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia

Cytokine-induced restoration of differentiation and cell cycle arrest in v-Myc transformed U-937 monoblasts correlates with reduced Myc activity.

Differentiation-related mechanisms which suppress DNA replication.

Multiple functions of p27(Kip1) and its alterations in tumor cells: a review.

Cyclin A2 transcriptional regulation: modulation of cell cycle control at the G1/S transition by peripheral cues.

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.

P304

853-862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2141.2005.05395.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7979649

http://www.w3.org/2001/XMLSchema#string

P698

15755292

http://www.w3.org/2001/XMLSchema#string

P921